Search filters

List of works by Michael D Jain

Advances in aggressive lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentary

scientific article published on 01 August 2018

Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma.

scientific article published on 17 August 2017

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin's lymphoma.

scientific article published on 31 May 2018

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

scientific article published on 01 December 2019

Cell Biology of the Endoplasmic Reticulum and the Golgi Apparatus through Proteomics

scientific article published on January 1, 2013

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies

scientific article

Cytokine release syndrome and neurologic toxicities associated with chimeric antigen receptor T-cell therapy: A comprehensive review of emerging grading models

scientific article published on 10 June 2019

Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder

scientific article published on 18 February 2020

Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy

scientific article published on 13 August 2019

High-resolution mapping of the Gli3 mutation extra-toes reveals a 51.5-kb deletion

scientific article published on 01 January 2002

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

scientific article published on 18 June 2019

Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel

scientific article published on 06 November 2020

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

scientific article published on 05 June 2019

Seek and you shall find--but then what do you do? Cold agglutinins in cardiopulmonary bypass and a single-center experience with cold agglutinin screening before cardiac surgery.

scientific article published on February 2013

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.

scientific article published on 7 February 2018

Tumor Microenvironment composition and severe cytokine release syndrome (CRS) Influence Toxicity in Patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel

scientific article published on 15 July 2020

Workplace-Based Assessment of Internal Medicine Resident Diagnostic Accuracy.

scientific article published on September 2014